Cancer patients experienced a fivefold decline in opioid dose prescriptions between 2016 and 2021, according to a study published March 26 in JCO Oncology Practice.  For the study, researchers from ...

Genomic Testing Cooperative (GTC) is expanding into the European market by partnering with German laboratory Labor Dr.

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

While U.S. health care is far from perfect, those facing diseases such as breast cancer stand far better odds in ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...

More than 50 nations have reached out to the White House to begin trade talks since U.S. President Donald Trump rolled out sweeping new tariffs, top officials said on Sunday as they defended levies ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

Uday R. Popat, MD, discusses promising findings from a phase 2 trial evaluating the JAK inhibitor itacitinib combined with ...